Telix Pharmaceuticals Ltd — Share Issue/Capital Change 2021

Jul 21, 2021

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

TELIX PHARMACEUTICALS LIMITED

Announcement Type

New announcement

Date of this announcement

Wednesday July 21, 2021

Details of +securities that have ceased

		Number of
ASX +security		+securities that	The +securities have	Date of
code	Security description	have ceased	ceased due to	cessation
TLXAJ	OPTION EXPIRING	50,000	Lapse of conditional right to	21/07/2021
	30-JUN-2024 EX $1.83		securities because the
			conditions have not been, or
			have become incapable of
			being, satisfied

Refer to next page for full details of the announcement

Notification of cessation of +securities

1 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Announcement Details

1.1 Name of +Entity

TELIX PHARMACEUTICALS LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type

ACN

Registration Number

616620369

1.3 ASX issuer code

TLX

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

21/7/2021

Notification of cessation of +securities

2 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

TLXAJ : OPTION EXPIRING 30-JUN-2024 EX $1.83

Unquoted +equity securities that have ceased

Number of securities that have ceased

50,000

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation Is the entity paying any consideration for the cessation? No 21/7/2021

Any other information the entity wishes to notify to ASX about the cessation?

Notification of cessation of +securities

3 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)	3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
TLX : ORDINARY FULLY PAID	281,623,408
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
TLXAJ : OPTION EXPIRING 30-JUN-2024 EX $1.83	1,300,000
TLXAD : OPTION EXPIRING 14-OCT-2021 EX 85C	3,349,500
TLXAI : OPTION EXPIRING 12-JAN-2024 EX $2.23	3,630,000
TLXAE : OPTION EXPIRING 11-JUN-2022 EX 85C	2,250,400
TLXAF : WARRANT EXPIRING VARIOUS DATES EX VARIOUS PRICES	780,923
TLXAG : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	6,245,000
TLXAK : RIGHTS	425,000
TLXAH : OPTION EXPIRING 03-NOV-2023 EX $2.30	1,710,000
TLXAL : OPTION EXPIRING 27-JAN-2026 EX $4.38	2,226,856

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities

4 / 4